Burnaby, British Columbia, and Columbia, MD April 9, 2019—LifeScan, Inc. today introduced the OneTouch Reveal Plus™ mobile app, which received Health Canada license and will soon be available to health benefit plans for adults living with type 1 and type 2 diabetes. Powered by Welldoc’s BlueStar® technology – OneTouch Reveal Plus™ will offer individualized, real-time…
Type: Press Release
Milwaukee, WI and Columbia, MD – April 3, 2019 – Today, Welldoc and Children’s Community Health Plan (CCHP) announced the introduction of BlueStar®, Welldoc’s FDA-cleared, proven digital therapeutic, to CCHP’s commercially-insured and Medicaid members. BlueStar, an in-app coach designed to engage people with type 2 diabetes, delivers personalized, real-time feedback, as well as diabetes educational tools that…
More than 10,000 Aetna members invited to use mobile app with artificial intelligence from Welldoc and LifeScan Inc. Hartford, CT and Columbia, MD – Today, Healthagen, an Aetna business unit within CVS Health, and Welldoc, in collaboration with LifeScan Inc., announced details of a study to evaluate the use and potential health benefits of OneTouch Reveal®…
Welldoc’s chronic disease portfolio grows with new features to support people with both type 1 and type 2 diabetes Columbia, MD – February 6, 2019 – Welldoc®, a leading digital health company, announced today its filing at the end of 2018 with the U.S. Food and Drug Administration (FDA) for 510(k) clearance of additional features…
Columbia, MD – January 7, 2019 – Welldoc®, a leading digital health company, announced today that it has secured a technology patent (based on U.S. Patent Application No. 15/923,010) from the United States Patent and Trademark Office for the Software Engine Technology that powers its BlueStar® digital therapeutic. “The awarding of this tenth technology patent…
Columbia, Maryland, November 9, 2018 – Welldoc®, a leading digital health company, announced today that its executives and digital health, diabetes and healthcare industry thought leaders will speak and/or participate in events at prominent diabetes and healthcare conferences this Fall. The list of events is as follows: 18th Annual Diabetes Technology Meeting November 8-10, 2018, Bethesda…
Columbia, MD October 15, 2018 – Welldoc® today announced that one of the world’s leading academic medical centers is moving into Phase 2 for ongoing Quality Improvement research of BlueStar, its FDA-cleared digital therapeutic, in the treatment of patients with type 2 diabetes within primary care. Principal investigator Daniel Henderson, MD, MPH, a primary care…
Baltimore, MD – August 30, 2018 – Welldoc®, a leading digital health company revolutionizing chronic disease management to help transform lives through the use of its digital therapeutics, announced today that Daniel Garrett, a digital health transformation consultant and recently retired partner at PricewaterhouseCoopers (PwC), has been appointed to Welldoc’s Board of Directors. “Dan brings…
– Malinda Peeples, RN, MS, CDE, Welldoc’s Vice President of Clinical Services, Programs and Research Recognized Today with AADE Allene Van Son Distinguished Service Award – Welldoc®, a leading digital health company revolutionizing chronic disease management to help transform lives through the use of its digital therapeutics, today announces its broad involvement at the American…
-BlueStar Provides One-Stop Solution for Managing Multiple Chronic Conditions – Welldoc®, a leading digital health company, today announces hypertension and weight management solutions integrated within its digital therapeutic app for type 2 diabetes, BlueStar®. Later this year, Welldoc will launch its stand-alone product for individuals living with hypertension (high blood pressure) and stand-alone products are…